Approval · Notice of Compliance 31279 · 2023
OMVOH: Notice of Compliance 31279
Issued July 20, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31279
- Date
- July 20, 2023
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- MIRIKIZUMAB 100 MG per ML
- MIRIKIZUMAB 20 MG per ML